Long-term follow-up of allogeneic haematopoietic stem cell transplantation for solid cancer

We wanted to determine whether allogeneic haematopoietic stem cell transplantation (HSCT) may result in long-term survival in patients with solid cancer. HSCT was performed in 61 patients with solid cancer: metastatic renal carcinoma (n=22), cholangiocarcinoma (n=17), colon carcinoma (n=15), prostate cancer (n=3), pancreatic adenocarcinoma (n=3), or breast cancer (n=1). Liver transplantation was performed for tumour debulking in 18 patients. Median age was 56 years (range 28‒77). Donors were either HLA-identical siblings (n=29) or unrelated (n=32).

Source: Biology of Blood and Marrow Transplantation - December 28, 2015 Category: Hematology Authors: Brigitta Omazic, Mats Remberger, Lisbeth Barkholt, Gunnar Söderdahl, Zuzana Potácová, Peter Wersäll, Bo-Göran Ericzon, Jonas Mattsson, Olle Ringdén Source Type: research